NCT02340520View on ClinicalTrials.gov

Enhancement of Corticosteroid Efficacy in COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
COPD
Interventions
DRUG

Theophylline

Oral

DRUG

Roflumilast

Oral

Trial Locations (1)

06032

UConnHealth, Farmington

All Listed Sponsors
lead

UConn Health

OTHER

NCT02340520 - Enhancement of Corticosteroid Efficacy in COPD | Biotech Hunter | Biotech Hunter